Stem definition | Drug id | CAS RN |
---|---|---|
peroxisome proliferator activating receptor-gamma (PPAR-gamma) agonists, thiazolidinedione derivatives | 2405 | 122320-73-4 |
Dose | Unit | Route |
---|---|---|
6 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 1 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 0.04 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 0 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 0.37 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 99 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Vd (Volume of distribution) | 0.20 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 0.65 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.00 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 3.90 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
May 25, 1999 | FDA | SB PHARMCO |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Cardiac failure congestive | 16777.07 | 162.76 | 4181 | 14733 | 80201 | 50506009 |
Myocardial infarction | 13616.55 | 162.76 | 3592 | 15322 | 85435 | 50500775 |
Coronary artery disease | 6104.37 | 162.76 | 1535 | 17379 | 28191 | 50558019 |
Cerebrovascular accident | 5758.01 | 162.76 | 1890 | 17024 | 92790 | 50493420 |
Acute myocardial infarction | 2752.64 | 162.76 | 821 | 18093 | 28452 | 50557758 |
Coronary arterial stent insertion | 1704.09 | 162.76 | 349 | 18565 | 2285 | 50583925 |
Coronary artery bypass | 1165.76 | 162.76 | 249 | 18665 | 2044 | 50584166 |
Angina unstable | 983.83 | 162.76 | 267 | 18647 | 6439 | 50579771 |
Myocardial ischaemia | 761.19 | 162.76 | 248 | 18666 | 11365 | 50574845 |
Vascular graft | 508.99 | 162.76 | 104 | 18810 | 667 | 50585543 |
Transient ischaemic attack | 500.66 | 162.76 | 243 | 18671 | 31967 | 50554243 |
Angina pectoris | 494.53 | 162.76 | 226 | 18688 | 25962 | 50560248 |
Chest pain | 441.02 | 162.76 | 428 | 18486 | 176454 | 50409756 |
Cardio-respiratory arrest | 403.74 | 162.76 | 251 | 18663 | 53641 | 50532569 |
Arteriosclerosis | 373.55 | 162.76 | 137 | 18777 | 8940 | 50577270 |
Acute coronary syndrome | 361.91 | 162.76 | 135 | 18779 | 9239 | 50576971 |
Cardiomyopathy | 321.01 | 162.76 | 143 | 18771 | 15443 | 50570767 |
Atrial fibrillation | 318.60 | 162.76 | 280 | 18634 | 101465 | 50484745 |
Arteriosclerosis coronary artery | 316.96 | 162.76 | 116 | 18798 | 7520 | 50578690 |
Sudden cardiac death | 314.74 | 162.76 | 84 | 18830 | 1888 | 50584322 |
Ischaemic cardiomyopathy | 301.50 | 162.76 | 84 | 18830 | 2228 | 50583982 |
Drug ineffective | 275.18 | 162.76 | 7 | 18907 | 819326 | 49766884 |
Cardiac arrest | 225.92 | 162.76 | 212 | 18702 | 83439 | 50502771 |
Nausea | 219.41 | 162.76 | 11 | 18903 | 705387 | 49880823 |
Cardiac disorder | 212.94 | 162.76 | 155 | 18759 | 42824 | 50543386 |
Fatigue | 194.43 | 162.76 | 20 | 18894 | 707581 | 49878629 |
Diarrhoea | 186.63 | 162.76 | 8 | 18906 | 588468 | 49997742 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Myocardial infarction | 18392.09 | 267.15 | 5710 | 19982 | 104586 | 29444249 |
Cardiac failure congestive | 14154.29 | 267.15 | 4321 | 21371 | 72260 | 29476575 |
Coronary artery disease | 9043.85 | 267.15 | 2718 | 22974 | 41472 | 29507363 |
Cerebrovascular accident | 5297.09 | 267.15 | 2102 | 23590 | 74809 | 29474026 |
Acute myocardial infarction | 3507.11 | 267.15 | 1378 | 24314 | 47060 | 29501775 |
Coronary artery bypass | 2659.93 | 267.15 | 650 | 25042 | 4035 | 29544800 |
Coronary arterial stent insertion | 2600.27 | 267.15 | 616 | 25076 | 3281 | 29545554 |
Angina unstable | 1156.41 | 267.15 | 412 | 25280 | 10453 | 29538382 |
Myocardial ischaemia | 836.98 | 267.15 | 363 | 25329 | 15665 | 29533170 |
Vascular graft | 794.71 | 267.15 | 194 | 25498 | 1186 | 29547649 |
Ischaemic cardiomyopathy | 622.86 | 267.15 | 220 | 25472 | 5418 | 29543417 |
Arteriosclerosis coronary artery | 529.89 | 267.15 | 233 | 25459 | 10372 | 29538463 |
Angina pectoris | 483.52 | 267.15 | 301 | 25391 | 27549 | 29521286 |
Transient ischaemic attack | 474.84 | 267.15 | 279 | 25413 | 22991 | 29525844 |
Acute coronary syndrome | 432.46 | 267.15 | 212 | 25480 | 12113 | 29536722 |
Arteriosclerosis | 422.53 | 267.15 | 197 | 25495 | 10059 | 29538776 |
Cardiomyopathy | 327.24 | 267.15 | 187 | 25505 | 14600 | 29534235 |
Cardio-respiratory arrest | 327.21 | 267.15 | 303 | 25389 | 50298 | 29498537 |
Sudden cardiac death | 296.86 | 267.15 | 110 | 25582 | 3112 | 29545723 |
Atrial fibrillation | 288.44 | 267.15 | 404 | 25288 | 105242 | 29443593 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Myocardial infarction | 30002.82 | 293.15 | 8330 | 28724 | 157491 | 64304187 |
Cardiac failure congestive | 27922.76 | 293.15 | 7502 | 29552 | 123078 | 64338600 |
Coronary artery disease | 11949.90 | 293.15 | 3308 | 33746 | 57125 | 64404553 |
Cerebrovascular accident | 10619.64 | 293.15 | 3656 | 33398 | 133927 | 64327751 |
Acute myocardial infarction | 6197.15 | 293.15 | 2071 | 34983 | 67647 | 64394031 |
Coronary arterial stent insertion | 4379.58 | 293.15 | 937 | 36117 | 4755 | 64456923 |
Coronary artery bypass | 3832.39 | 293.15 | 843 | 36211 | 4972 | 64456706 |
Angina unstable | 1856.89 | 293.15 | 580 | 36474 | 14887 | 64446791 |
Vascular graft | 1292.61 | 293.15 | 282 | 36772 | 1577 | 64460101 |
Myocardial ischaemia | 1248.34 | 293.15 | 478 | 36576 | 22773 | 64438905 |
Angina pectoris | 837.40 | 293.15 | 441 | 36613 | 44640 | 64417038 |
Transient ischaemic attack | 777.66 | 293.15 | 417 | 36637 | 43765 | 64417913 |
Arteriosclerosis | 661.55 | 293.15 | 272 | 36782 | 15605 | 64446073 |
Cardio-respiratory arrest | 642.58 | 293.15 | 497 | 36557 | 97896 | 64363782 |
Acute coronary syndrome | 642.51 | 293.15 | 282 | 36772 | 19028 | 64442650 |
Chest pain | 630.90 | 293.15 | 725 | 36329 | 235255 | 64226423 |
Sudden cardiac death | 520.60 | 293.15 | 165 | 36889 | 4422 | 64457256 |
Arteriosclerosis coronary artery | 497.88 | 293.15 | 221 | 36833 | 15308 | 64446370 |
Ischaemic cardiomyopathy | 486.13 | 293.15 | 173 | 36881 | 6665 | 64455013 |
Drug ineffective | 453.48 | 293.15 | 6 | 37048 | 840241 | 63621437 |
Nausea | 409.86 | 293.15 | 9 | 37045 | 785791 | 63675887 |
Cardiomyopathy | 386.98 | 293.15 | 218 | 36836 | 25138 | 64436540 |
Diarrhoea | 373.95 | 293.15 | 9 | 37045 | 722695 | 63738983 |
Fatigue | 367.14 | 293.15 | 15 | 37039 | 748715 | 63712963 |
Cardiac arrest | 359.03 | 293.15 | 442 | 36612 | 153622 | 64308056 |
Atrial fibrillation | 349.99 | 293.15 | 460 | 36594 | 170629 | 64291049 |
Dyspnoea | 298.46 | 293.15 | 33 | 37021 | 718641 | 63743037 |
Pyrexia | 296.48 | 293.15 | 5 | 37049 | 558639 | 63903039 |
Vomiting | 296.45 | 293.15 | 4 | 37050 | 551113 | 63910565 |
None
Source | Code | Description |
---|---|---|
ATC | A10BD03 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Combinations of oral blood glucose lowering drugs |
ATC | A10BD04 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Combinations of oral blood glucose lowering drugs |
ATC | A10BG02 | ALIMENTARY TRACT AND METABOLISM DRUGS USED IN DIABETES BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS Thiazolidinediones |
FDA CS | M0199114 | PPAR gamma |
FDA CS | M0447306 | Thiazolidinediones |
FDA MoA | N0000175374 | Peroxisome Proliferator-activated Receptor Activity |
MeSH PA | D007004 | Hypoglycemic Agents |
FDA EPC | N0000180186 | Peroxisome Proliferator Receptor gamma Agonist |
FDA EPC | N0000180190 | Thiazolidinedione |
CHEBI has role | CHEBI:50864 | insulin sensitizers |
CHEBI has role | CHEBI:83157 | EC 6.2.1.3 inhibitors |
CHEBI has role | CHEBI:173084 | ferroptosis inhibitors |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Treatment Refractory Type 2 Diabetes Mellitus | indication | ||
Alcoholism | contraindication | 7200002 | |
Weight gain finding | contraindication | 8943002 | |
Asthenia | contraindication | 13791008 | |
Pulmonary edema | contraindication | 19242006 | DOID:11396 |
Myocardial infarction | contraindication | 22298006 | DOID:5844 |
Acute vomiting | contraindication | 23971007 | |
Alcohol intoxication | contraindication | 25702006 | |
Shock | contraindication | 27942005 | |
Dehydration | contraindication | 34095006 | |
Macular retinal edema | contraindication | 37231002 | DOID:4449 |
Infectious disease | contraindication | 40733004 | |
Body fluid retention | contraindication | 43498006 | |
Chronic heart failure | contraindication | 48447003 | |
Hepatic porphyria | contraindication | 55056006 | DOID:3133 |
Ketoacidosis | contraindication | 56051008 | |
Metabolic acidosis | contraindication | 59455009 | |
Hemolytic anemia | contraindication | 61261009 | DOID:583 |
Glucose-6-phosphate dehydrogenase deficiency anemia | contraindication | 62403005 | |
Osteoporosis | contraindication | 64859006 | DOID:11476 |
Hypopituitarism | contraindication | 74728003 | DOID:9406 |
Cardiogenic shock | contraindication | 89138009 | |
Kidney disease | contraindication | 90708001 | DOID:557 |
Lactic acidosis | contraindication | 91273001 | DOID:3650 |
Fracture of bone | contraindication | 125605004 | |
Autonomic dysreflexia | contraindication | 129618003 | |
Liver function tests abnormal | contraindication | 166603001 | |
Cobalamin deficiency | contraindication | 190634004 | |
Angina pectoris | contraindication | 194828000 | |
Decompensated cardiac failure | contraindication | 195111005 | |
Cerebrovascular accident | contraindication | 230690007 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Drug-induced hepatitis | contraindication | 235876009 | |
Hypoglycemic disorder | contraindication | 237630007 | |
Sepsis syndrome | contraindication | 238150007 | |
Osteopenia | contraindication | 312894000 | |
Primary adrenocortical insufficiency | contraindication | 373662000 | |
Adrenal cortical hypofunction | contraindication | 386584007 | DOID:10493 |
Fever | contraindication | 386661006 | |
Surgical procedure | contraindication | 387713003 | |
Severe diarrhea | contraindication | 409587002 | |
Breastfeeding (mother) | contraindication | 413712001 | |
Disorder of coronary artery | contraindication | 414024009 | |
Myocardial ischemia | contraindication | 414795007 | DOID:3393 |
Traumatic injury | contraindication | 417746004 | |
Fever greater than 100.4 Fahrenheit | contraindication | 426000000 | |
Radiography with IV Iodinated Contrast Agent | contraindication | ||
Severe Hypoxemia | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 6.5 | acidic |
pKa2 | 5.84 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | AGONIST | EC50 | 7.04 | WOMBAT-PK | CHEMBL | |||
Carbonic anhydrase 2 | Enzyme | IC50 | 5.39 | DRUG MATRIX | |||||
Bile salt export pump | Transporter | IC50 | 5.19 | CHEMBL | |||||
Amine oxidase [flavin-containing] B | Enzyme | Ki | 5.38 | CHEMBL | |||||
Amine oxidase [flavin-containing] A | Enzyme | Ki | 4.56 | CHEMBL | |||||
Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | EC50 | 7.41 | CHEMBL | |||||
Retinoic acid receptor RXR-alpha | Nuclear hormone receptor | Kd | 4.82 | CHEMBL | |||||
Retinoic acid receptor gamma | Nuclear hormone receptor | Ki | 5 | CHEMBL | |||||
Thromboxane-A synthase | Enzyme | IC50 | 5.45 | DRUG MATRIX | |||||
Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | EC50 | 5.44 | CHEMBL | |||||
Free fatty acid receptor 1 | GPCR | AGONIST | EC50 | 5.60 | IUPHAR | ||||
Short transient receptor potential channel 5 | Ion channel | ACTIVATOR | EC50 | 4.51 | IUPHAR | ||||
Sodium/bile acid cotransporter | Transporter | IC50 | 5.29 | CHEMBL | |||||
CDGSH iron-sulfur domain-containing protein 1 | Unclassified | Ki | 7.51 | CHEMBL | |||||
Potassium voltage-gated channel subfamily H member 2 | Ion channel | IC50 | 4.53 | CHEMBL | |||||
CDGSH iron-sulfur domain-containing protein 2 | Unclassified | IC50 | 5.64 | CHEMBL | |||||
Amine oxidase [flavin-containing] B | Enzyme | Ki | 5.24 | CHEMBL | |||||
Amine oxidase [flavin-containing] A | Enzyme | Ki | 4.49 | CHEMBL | |||||
Peroxisome proliferator-activated receptor alpha | Transcription factor | IC50 | 7.10 | CHEMBL | |||||
Peroxisome proliferator-activated receptor gamma | Transcription factor | EC50 | 7.52 | CHEMBL | |||||
Type-1A angiotensin II receptor | GPCR | Ki | 9.64 | CHEMBL | |||||
Bile salt export pump | Transporter | IC50 | 4.40 | CHEMBL | |||||
CDGSH iron-sulfur domain-containing protein 1 | Unclassified | IC50 | 5.96 | CHEMBL |
ID | Source |
---|---|
4021162 | VUID |
N0000148613 | NUI |
D00596 | KEGG_DRUG |
155141-29-0 | SECONDARY_CAS_RN |
4021162 | VANDF |
4021163 | VANDF |
C0289313 | UMLSCUI |
CHEBI:50122 | CHEBI |
BRL | PDB_CHEM_ID |
CHEMBL121 | ChEMBL_ID |
DB00412 | DRUGBANK_ID |
CHEMBL843 | ChEMBL_ID |
D000077154 | MESH_DESCRIPTOR_UI |
77999 | PUBCHEM_CID |
1056 | IUPHAR_LIGAND_ID |
7662 | INN_ID |
302543-62-0 | SECONDARY_CAS_RN |
05V02F2KDG | UNII |
253198 | RXNORM |
8221 | MMSL |
d04434 | MMSL |
007789 | NDDF |
007790 | NDDF |
116096001 | SNOMEDCT_US |
326053005 | SNOMEDCT_US |
395869000 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Avandia | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-4198 | TABLET, FILM COATED | 4 mg | ORAL | NDA | 19 sections |
Avandia | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-4221 | TABLET, FILM COATED | 8 mg | ORAL | NDA | 19 sections |
AVANDAMET | HUMAN PRESCRIPTION DRUG LABEL | 2 | 54868-4965 | TABLET, FILM COATED | 2 mg | ORAL | NDA | 30 sections |
AVANDAMET | HUMAN PRESCRIPTION DRUG LABEL | 2 | 54868-5157 | TABLET, FILM COATED | 4 mg | ORAL | NDA | 30 sections |
Avandia | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-5249 | TABLET, FILM COATED | 2 mg | ORAL | NDA | 19 sections |
AVANDAMET | HUMAN PRESCRIPTION DRUG LABEL | 2 | 54868-5262 | TABLET, FILM COATED | 4 mg | ORAL | NDA | 30 sections |
AVANDAMET | HUMAN PRESCRIPTION DRUG LABEL | 2 | 54868-5376 | TABLET, FILM COATED | 2 mg | ORAL | NDA | 30 sections |